Effect of ethane-I-hydroxy-I, I-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation.
The present study was undertaken to examine changes in vascular ultrastructure of rats subjected to hypervitaminosis D with or without treatment with ethane-I-hydroxy-I, I-diphosphonate (EHDP). Five groups of rats were studied. Untreated rats were given 0.9% NaCl i.p. Sham-treated rats were given vehicle (corn oil). Treated rats were given ergocalciferol (75,000 IU i.p.) dissolved in vehicle with or without EHDP (5 mM/100 g body-weight i.p.). Rats which had been given ergocalciferol without EHDP developed hypercalcemia and demonstrated significant arterial calcinosis. A similar degree of calcinosis was not observed in rats given ergocalciferol with EHDP. EHDP appeared to inhibit arterial calcinosis; however, it did not affect plasma calcium levels. This suggests that EHDP might delay calcium influx into the cell and thereby prevent calcium overload. Our findings support the suggestion that EHDP therapy can be an effective treatment for the inhibition of dystrophic arterial calcinosis.
Kingma
J G
JG
Research Center, Quebec Heart Institute, Canada.
Roy
P E
PE
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000648:ultrastructure; D001018:Aortic Diseases / Q000139:chemically induced / Q000473:pathology*; D002114:Calcinosis / Q000139:chemically induced / Q000473:pathology*; D004872:Ergocalciferols / Q000008:administration & dosage*; D012968:Etidronic Acid / Q000494:pharmacology*; D008297:Male; D008854:Microscopy, Electron; D051381:Rats; D011919:Rats, Inbred Strains
D004872:Ergocalciferols; D012968:Etidronic Acid